
Kim-Hien Thi Dao DO PhD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor, Knight Cancer Institute, Oregon Health and Science University School of Medicine
Join to View Full Profile
875 Oak StSte 4030Salem, OR 97301
Phone+1 503-561-6444
Fax+1 503-561-6440
Dr. Dao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
- Scripps Mercy HospitalResidency, Internal Medicine, 2003 - 2006
- Michigan State University College of Osteopathic MedicineClass of 2003
Certifications & Licensure
- OR State License 2009 - 2025
- CA State License 2004 - 2010
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia Start of enrollment: 2014 Jul 08
- A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) Start of enrollment: 2020 May 21
Publications & Presentations
PubMed
- Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.Michael R Savona, Olatoyosi Odenike, Gail J Roboz, Harshad Amin, Amy E DeZern
British Journal of Haematology. 2025-06-16 - 29 citationsOral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised...Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan
The Lancet. Haematology. 2024-01-01 - 11 citationsInsights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.Ryan C. Stoner, Richard D. Press, Julia E. Maxson, Jeffrey W. Tyner, Kim Hien T. Dao
Leukemia. 2020-06-01
Other Languages
- Vietnamese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: